Psychedelics Today

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, Chief Science Officer, and Director of Analytical Science at the Alexander Shulgin Research Institute (ASRI), focusing on the discovery and development of novel psychedelic compounds. While Sasha was passionate about self-experimentation, the Institute is aiming for the next step for these drugs: FDA approval.   He discusses:  Meeting Sasha at the 2nd international conference on hallucinogenic mushrooms in Washington D.C. Bonding with Sasha while reviewing the autopsy of researcher Robert van den Bosch for possible foul play The two compounds ASRI is closest to being able to test in clinical trials The 5-HT2B receptor, risk of valvular disease, and why we will likely be hearing more about this going forward How AI and new technology can lead to better safety science   and more! Click here to head to the show notes page.

In this episode, David interviews Osiris González Romero: philosopher and Postdoctoral researcher on cognitive freedom and psychedelic humanities at the University of Saskatchewan. Romero believes that our weakest point of research is our knowledge of Indigenous languages, and is focused on highlighting different cultural uses of psychedelics to better inform future drug policy. He’s currently studying more than 100 documents (including one over 400 years old) to establish an honest understanding of why peyote was ever banned. He discusses: Mesoamerican psychedelics and their relevance to cognitive liberty and decolonization How the War on Drugs is our main colonial legacy The concepts of an ontological turn and ontological pluralism The neocolonial, biomedical, and spiritual paradoxes found inside the ‘psychedelic renaissance’ How imagination is often viewed through a lens of illusion rather than problem solving or creativity and more! Click here to head to the show notes page. 

Maria Mangini, Ph.D., FNP, shares her journey from psychedelic pioneers to midwifery. Discussions include the Shulgins' partnership, Denis Berry's archival work, and the parallels between midwifery and psychedelic therapy. Explore the societal balance represented by the Shulgins, and the unsung heroes of the psychedelic movement.

In this episode, released on Ann Shulgin’s birthday, Joe interviews Wendy Tucker: daughter of Ann and stepdaughter to Alexander “Sasha” Shulgin. Recorded in Sasha’s old office, she recounts her formative years, giving an insider’s look into her Mother’s openness about psychedelics, working with Sasha in the lab, how the Shulgins made a perfect team, and watching a close-knit circle of self-experimenters start to form at Shulgin Farm – and keep coming back over the years. She talks about the energy infused into the property from the decades of research and gatherings, and how she is trying to preserve it – not just to capture its history and the pioneering research that happened there, but as a beacon for future generations. She imagines weddings, conferences, other communal gatherings, and more. Imagine taking a chemistry course in Sasha Shulgin’s lab? To learn more about the project and to donate, head to Shulginfarm.org. Click here to head to the show notes page and watch the video.

Juan Pablo Cappello, co-founder of Nue Life Health, talks about the ethical issues of at-home ketamine therapy, emphasizing the focus on long-term benefits over profit. He discusses industry standards, Matthew Perry's death, and the need for ethical practices in the psychedelic community.

In this episode, David interviews Dr. 1Drea Pennington Wasio: integrative physician, psychedelic-assisted therapy facilitator and psilocybin retreat leader, international speaker, podcaster, and author of several books, including "Sacred Medicine: Exploring The Psychedelic Hero’s Journey." She discusses her personal metamorphosis and name change inspired by a powerful ayahuasca experience, and how that moved her into a life more inspired by authenticity and self-love. She gives the details of her retreats, explains her PRISM sessions, and talks in depth about the magic of resiliency: How can we not just return to baseline, but experience post-traumatic growth? She talks about: The power of tuning into creativity in times of depression The efficacy of narrative therapy and writing in general The universal themes of ‘The Hero’s Journey’ and how much agency matters The importance of embracing nonfiction, and her upcoming book series, "The Dreamweaver’s Legacy" The potential of microdosing psilocybin for menopause and more! Her new course on trauma-informed psychedelic therapy begins this month, and her next retreat begins May 10. Head to 1drea.com for details. Click here to head to the show notes page. 

In this episode, David interviews Itzhak Beery: author, shamanic teacher, speaker, trip leader, and founder of ShamanPortal.org, an online community and resource for people who want to learn, practice, and teach shamanic traditions. Beery shares his transformational journey, starting from his upbringing on a kibbutz in Israel, to his disillusioned advertising days in Manhattan, to the life-altering sweat lodge experience in Hawaii that eventually led him to write the book, Shamanic Transformations: True Stories of the Moment of Awakening, and realize his true purpose. He discusses the two major sides of trust: how to know when a healing path has truly become your life purpose, and how to know who to trust as a good healer in a world of self-initiated shamans. He and David dig into: How we all have the innate ability to be a shaman How Westerners are often seeking healing too young, before they have the capacity to truly understand lessons they may receive His upcoming book which attempts to teach practitioners how to create narratives out of symbols, The Language of Spirit The importance in not denying the experiencer’s truth and more! Click here to head to the show notes page.

In this episode, Johanna interviews Laura Reeves: Glastonbury-based facilitator and medicine woman trained in craniosacral therapy, somatic experiencing, breathwork, and more, who holds retreats at sacred sites in the U.K. and Peruvian Amazon. She tells of her journey from serendipitously booking a trip to Ecuador just as she first heard about ayahuasca, to the early ayahuasca experiences that showed her our true interconnectedness, to a heroic dose of psilocybin and a trip to the hospital, to being accepted into training with an Indigenous shaman in the Amazon. With a lifelong love of nature, paganism, and ancient traditions, she stresses the importance of connecting to the natural rhythms of the Earth and harnessing its energy. She talks about: Self-initiated shamans and the dangers that can come from bad actors operating out of integrity and respect for the lineage Ayahuasca as a purgative and the power of energetic clearings Her experience with shamans using Icaros to channel the sounds of plants Shadow work and its role in personal growth and healing The energy of Glastonbury, feeling deep connections to sacred places, and how ley lines inspire places of pilgrimage and more! Click here to head to the show notes page. 

In this episode, Joe and guest co-host Erica Rex interview Elizabeth Anglin: spirit medium, animal communicator, intuitive healer, alien abductee, and author of Experience: Memoirs of an Abducted Childhood. She talks about her early abduction experiences, the time when she and her father realized they were both being abducted at the same time (from different locations), and the horrifying experience of six beings entering her apartment and realizing she knew one of them. These experiences led her to Budd Hopkins, and eventually John Mack (who did regression work with her) and the John E. Mack Institute, where she became a peer mentor for abductees. She talks about the validity of alien abductions, the concept of spiritual ecology, and the importance of listening to people: There’s so much we don’t know, so is it fair to label experiencers as schizophrenic just because we can’t replicate the experience? She discusses: The commonality of people from the same family being abducted and why some people are lifetime abductees while others are only taken once The differences in abductions and how some seem to only be mental while others are physical and extremely painful The story of Linda Napolitano and the famous Brooklyn Bridge abduction Regressive hypnotherapy work: Are the memories you’re recovering accurate? Quantum biology, the Penrose-Hameroff quantum theory of consciousness, parallel realities, time travel, and quantum jumping and so much more! As the X-Files made famous: The truth is out there. And this episode is definitely pretty out there! Click here to head to the show notes page.

In this episode, Christopher Koddermann interviews Dr. Sam Banister: co-founder and chief scientific officer of Psylo, an Australian biotech company developing next-generation psychedelics. Banister discusses how he got involved in drug development, how Psylo came about, and the hallucinogenic and non-hallucinogenic 5-HT2A agonists Psylo is working on. He talks about the compromise between immediate need and ambition, and the ethical considerations and possibilities behind developing non-hallucinogenic compounds: What can we take from the psychedelic experience for people who aren’t ideal candidates for one? Is the psychedelic experience truly necessary? And for what indications will these new Gen 3 compounds be most useful? He discusses: What we can infer about the volatility of biotech and the state of the psychedelic industry based on recent mergers and acquisitions The long-term challenges of drug development and the scalability of treatment options How the initial success of Spravato has played a role in allaying fears around new compounds Head twitch response and concerns it’s not as accurate of a metric as we’ve believed Australia’s decision to down-schedule psilocybin and MDMA, and the speed of implementation and licensing: How long will it be before people have easy access? What he sees for the future and why we need to be careful with language around expectations and more! Click here to head to teh show notes page.